CJ Bioscience Inc.
CJ Bioscience Inc. operates in Health Care Technology.
Market Cap & Net Worth: CJ Bioscience Inc. (311690)
CJ Bioscience Inc. (KO:311690) has a market capitalization of $54.45K (₩79.73 Million) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #42146 globally and #2336 in its home market, demonstrating a -4.51% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CJ Bioscience Inc.'s stock price ₩8690.00 by its total outstanding shares 9175 (9.18K).
CJ Bioscience Inc. Market Cap History: 2019 to 2025
CJ Bioscience Inc.'s market capitalization history from 2019 to 2025. Data shows change from $235.61K to $54.45K (-22.28% CAGR).
CJ Bioscience Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CJ Bioscience Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 311690 by Market Capitalization
Companies near CJ Bioscience Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to CJ Bioscience Inc. by market ranking:
- CHINA MERCHANT -H- (MU:M4B): Ranked #42137 globally with a market cap of $54.78K USD ( €53.37K EUR).
- RENTOKIL INITIAL (MU:RTO1): Ranked #42138 globally with a market cap of $54.75K USD ( €53.34K EUR).
- Ceylon Tobacco Company PLC (CM:CTCN0000): Ranked #42147 globally with a market cap of $54.47K USD ( SLRs15.89 Million LKR).
- Black Sea Property PLC Ordinary Shares (TA:BSP): Ranked #42148 globally with a market cap of $54.45K USD ( ILA20.31 Million ILA).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #42137 | CHINA MERCHANT -H- | MU:M4B | $54.78K | €5.41 |
| #42138 | RENTOKIL INITIAL | MU:RTO1 | $54.75K | €5.56 |
| #42147 | Ceylon Tobacco Company PLC | CM:CTCN0000 | $54.47K | SLRs1692.00 |
| #42148 | Black Sea Property PLC Ordinary Shares | TA:BSP | $54.45K | ILA2250.00 |
CJ Bioscience Inc. Historical Marketcap From 2019 to 2025
Between 2019 and today, CJ Bioscience Inc.'s market cap moved from $235.61K to $ 54.45K, with a yearly change of -22.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₩54.45K | -13.88% |
| 2024 | ₩63.23K | -37.48% |
| 2023 | ₩101.14K | -44.34% |
| 2022 | ₩181.72K | -40.45% |
| 2021 | ₩305.16K | -4.88% |
| 2020 | ₩320.83K | +36.17% |
| 2019 | ₩235.61K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CJ Bioscience Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $54.45K USD |
| MoneyControl | $54.45K USD |
| MarketWatch | $54.45K USD |
| marketcap.company | $54.45K USD |
| Reuters | $54.45K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.